VERA Financial Facts
Selling, general and administrative: 1.89MCost of revenues: 1.63M
See Full Income Statement
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 14.05M
Total Current Liabilities: 8.06M
See Full Balance Sheet
Vera Therapeutics, Inc. (VERA) Earnings
|
Expand Research on VERA
| Next EPS Date | 11/11/26 | EPS Growth Rate | -27.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -18.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +7.3% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$1.61 | N/A | N/A | $4.28M | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | -$1.52 | -$1.65 | +$0.13 | N/A | N/A | N/A |  | | Details | |
| 5/7/26 | Q126 | -$1.69 | -$1.33 | -$0.36 | N/A | N/A | N/A | | | Details | |
| 3/19/26 |
Q425 | N/A | -$1.28 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 | Q325 | -$1.26 | -$1.15 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 8/5/25 |
Q225 | -$1.20 | -$0.82 | -$0.38 | N/A | N/A | N/A | | | Details | |
| 5/6/25 |
Q125 | N/A | -$0.73 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/20/25 |
Q424 | N/A | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A |
